Salute e Benessere
Contura Orthopedics Expands to Canada, Bringing Arthrosamid® to North America
Osteoarthritis is the most common form of arthritis, affecting millions worldwide and imposing a significant burden on healthcare systems. suffer from OA, with knee osteoarthritis being a leading cause of pain, mobility issues and reduced quality of life. As the population ages and obesity rates rise, the prevalence of OA continues to grow, increasing the demand for effective, long-term solutions for pain management.
Despite the widespread impact of knee osteoarthritis, Many patients rely on painkillers or corticosteroid injections, which offer only temporary relief, while others face the prospect of invasive knee replacement surgery. Innovation in OA management is crucial to bridging this gap and providing patients with better solutions that improve mobility and long-term joint function.
Arthrosamid® (2.5% iPAAG) is a unique designed to provide long-lasting pain relief for knee osteoarthritis sufferers. Unlike traditional OA injections, Arthrosamid® integrates into the synovial tissue of the knee, helping to reduce pain with a without surgery. Clinical studies have demonstrated offering patients an innovative new option in OA care.
To lead our efforts in Canada , we are pleased to welcome as our . Peter brings a wealth of experience in the medical device and pharmaceutical industries, with a proven track record of successfully bringing novel therapies to market. His leadership will be instrumental in ensuring that Canadian patients and healthcare professionals have access to Arthrosamid®.
Contura Orthopedics remains dedicated to advancing patient care by delivering innovative and clinically proven solutions to the global orthopedic community.
Contura Orthopaedics Ltd is a division of Contura International Ltd., a leading innovator in medical products for orthopaedics, soft tissue augmentation and animal health. Headquartered in London, UK , with state-of-the-art manufacturing in Copenhagen, Denmark , we specialise in using our patented hydrogel technology to create products which make a meaningful difference in the lives of patients across the world. Contura International Ltd. is committed to providing the highest quality products via its team of experienced professionals who are dedicated to quality control and manufacturing excellence.
Photo: https://mma.prnewswire.com/media/2627202/Arthrosamid.jpg
View original content:https://www.prnewswire.co.uk/news-releases/contura-orthopedics-expands-to-canada-bringing-arthrosamid-to-north-america-302384466.html